MAPT and Alzheimer disease: In this analysis, CSF Ng was significantly increased in the high-level pathology AD group having most widespread tau (p = 0.0007) and Aβ plaque (p = 0.0002) pathology compared to no (or negligible) AD pathology (Fig. 6b, c).